Does the frequency of molecular monitoring after tyrosine kinase inhibitor discontinuation affect outcomes of patients with chronic myeloid leukemia?

Outcomes of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Following an Elective Switch From Second-Generation Tyrosine Kinase Inhibitor to Imatinib

Exploratory study on the impact of switching to nilotinib in 18 patients with chronic myeloid leukemia in chronic phase with suboptimal response to imatinib

Augusta University is Georgia's health sciences university and a national center for cyber security education. Home to the state’s only public academic medical center, Augusta’s world-class clinicians are bringing the medicine of tomorrow to patient care today. The university is comprised of nine colleges, including one of the nation's oldest medical schools, the Medical College of Georgia; the Hull College of Business; and the state's only dental school, the Dental College of Georgia.

Augusta University

Dr. Anand P. Jillella returned to the Medical College of Georgia at Augusta University in July 2017 as the J. Harold Harrison, MD, Distinguished University Chair in Medical Oncology. He also serves as the associate director of Medical Oncology Services at the Georgia Cancer Center. Dr. Jillella is the founding director of the Georgia Cancer Center’s adult stem cell and bone marrow transplant program.

Jillella’s current research, funded by the Leukemia/Lymphoma Society, is a novel induction therapy for acute promyelocytic leukemia, a cancer of the white blood cells, which dramatically reduces mortality rates and starts as a national ECOG/ACRIN clinical trial. His clinical focus is bone marrow transplantation for leukemia, multiple myeloma and other blood-related malignancies.

Bone Marrow Transplantation

Leukemia

Acute Promyelocytic Leukemia

Hematology Oncology

Cancer clinical trials

Cancer

News and press release archive for Anand Jillella

Faculty Directory Profile

Dr. Anand Jillella receives Georgia CORE’s Optimistic Oncologist Award

Unique Trial Aims to Decrease Early Deaths in Patients with Rare Leukemia

A national study to cure a specific form of leukemia happening in Augusta

Jillella returns as J. Harold Harrison MD Chair for Medical Oncology

Chief, Division of Hematology/Oncology

Dr. Anand P. Jillella returned to the Medical College of Georgia at Augusta University July 1 as the J. Harold Harrison, MD, Distinguished University Chair in Medical Oncology. Watch to find out what brought Dr. Jillella home, and what he plans to do to make the Georgia Cancer Center the No. 1 resource for cancer patients in east Georgia and westSouth Carolina.

3Qs with Dr. Anand Jillella: Serving patients, coming home

Winship Cancer Institute leukemia specialist Dr. Anand Jillella has come up with a way to save patients' lives following diagnosis of acute promyelocytic leukemia. Treating the deadly disease shortly after diagnosis is critical.

View Dr. Jillella's bio: https://winshipcancer.emory.edu/bios/faculty/jillella-anand.html

Learn more about Winship Cancer Institute: http://winshipcancer.emory.edu

Treating APL: The "Heart Attack" of Leukemias

Anand P. Jillella, MD of the Winship Cancer Institute of Atlanta, GA, discusses best practices, treatment, standard of care for APL, role of clinical trials, complications that may arise during treatment, treating a relapsed patient, and the importance of a good relationship with your patients. Kaitlin L. Sitchenko, CCRC discusses the role of clinical trials in treatment. APL survivors, Julie and June each share their story about their APL diagnosis and treatment. 

To view additional videos, visit http://www.LLS.org/educationvideos. 
or your feedback at http://www.cancereducation.com/cancer.... 
Support for this video provided by Teva Oncology.

Treating Acute Promyelocytic Leukemia (APL)

Select Inquiry Type